Brii Biosciences Ltd. (China) Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-555.00
-203.00
-569.00
-5,051.00
-1,442.00
-590.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-54.00
-133.00
-89.00
-402.00
529.00
29.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-317.00
-538.00
-537.00
-1,059.00
-452.00
-77.00
Cash Flow from Investing Activities
977.00
-234.00
-1,705.00
-579.00
-51.00
-105.00
Cash Flow from Financing Activities
-7.00
-11.00
-2.00
3,894.00
740.00
589.00
Net Cash Inflow / Outflow
653.00
-775.00
-1,933.00
2,189.00
173.00
407.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
9.00
311.00
-66.00
-61.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Brii Biosciences Ltd. (China)
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-555.535696646242
17.7473915779983
-572.00
-3230.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-54.6546396768038
-62.3409045054508
8.00
12.33%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-317.110536784157
35.6246104535678
-352.00
-990.14%
Cash Flow from Investing Activities
977.432130913078
-529.481159049957
1,506.00
284.60%
Cash Flow from Financing Activities
-7.63293585123091
400.11907596161
-407.00
-101.91%
Net Cash Inflow / Outflow
653.275223376485
-93.7374726347796
746.00
796.92%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.586565098794875
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 41.14% vs -0.17% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-317.11
-538.74
41.14%






